eFoodSafety's Cinnergen(TM) is Now Supported by Vital Web-Based Broker Network

eFoodSafety.com, Inc. (OTCBB:EFSF) today announced that for those suffering from diabetes and related blood sugar problems, Cinnergen™, a product based on natural food services, which helps control blood sugar levels, will now be available on a host of retail websites at affordable prices, featuring streamlined shipping. The dramatic launch of http://www.cinnergen.com will not only be good news for those using the product, but present a fantastic opportunity for those wishing to be part of an innovative, proprietary software developed to facilitate Internet Marketing of Cinnergen. Brokers will profit from the extraordinary product outreach fostered by national advertising on CNN and the Weather channel, PR activity on local television outlets throughout the country and widespread print advertising. Considering the value of this Cinnergen in a market for diabetes treatments dominated by synthetic products and natural by products, Cinnergen, Inc., expects its product to explode on the Internet. "This is not just an ordinary product. It offers a unique alternative to other diabetes treatment products used to control diabetes and related blood sugar problems. We think that a product like this literally deserves to be online. People don’t want to have to always truck over to a retail store for an essential product they will probably be using on a regular basis,” says Daniel Taft, who is spearheading the Internet Marketing Campaign. "Our brokers will find that their Cinnergen sites are among the most efficient and trouble-free product-oriented websites around backed with a considerable investment in sophisticated Internet Marketing. We believe our on-line marketing will accelerate the growth of this already highly successful product. More and more people look for health information on the Internet, over a hundred million people, a ten-fold growth since the turn of the century.” Cinnergen is not a laboratory-created, synthetic drug, despite the fact that 52% of patients using it were able to dispense with all other medications that lower glucose content in the blood. The fact is Cinnergen is much more like a whole food source than any kind of patented pharmaceutical created synthetically. Its 12 whole food concentrates, coming from powerful natural herbs like cinnamon bark, oat seed, blueberry leaf, kelp, cranberry, black cherry- and others, have a track record spanning centuries of usage in the area of treating diabetes, kidney and urinary tract problems with the end result of clinically proved success in the control of blood sugar levels. These clinical studies give legs to the claims that herbal medicine has performed beneficially throughout the ages and that, indeed, the stories of herbal medicines being useful in the treatment of diabetes and to lower glucose in the blood have enhanced credibility to the scientific observer. Cinnamon bark, a featured ingredient in Cinnergen, has been used in Chinese medicine for centuries, but has recently come into the scientific limelight through its role in improving blood sugar levels. "Owing to the remarkable value of this product and other products we soon hope to be marketing, we are insisting that our sales representatives be certified and have a complete knowledge of our products,” continues Daniel Taft. "We intend to equip them with WMC and TGS marketing website management tools that would make any serious Internet Marketer eager to work with us, utilizing the same high-powered type of software that only giant corporations have traditionally used. We promise them hefty commissions based on their performance. But, best of all, they have the opportunity to help thousands of people with a unique combination of herbal whole foods that can help control naturally one of the most devastating conditions of our time, diabetes and other blood-related problems.” About Natural Source Products, LLC For more information, contact Daniel Taft, President of Natural Source Products, LLC, at 928-468-6480 or email him at danieltaft@naturalsourceproducts.com. About eFoodSafety.com, Inc. eFoodSafety.com, Inc. is dedicated to improving health conditions around the world through its innovative technologies. The company’s Knock-Out Technologies, Ltd. subsidiary has developed an environmentally safe sporicidal product formulated entirely of food-grade components that eradicates anthrax and a germicidal product, Citroxin (formerly named Big Six Plus) – EPA Reg. No. 82723-1 that kills six major bacteria: E-coli, Listeria, Pseudomonas, Salmonella, Staphylococcus, and Streptococcus, Avian Influenza, and Black Mold. The sporicidal product has completed its final efficacy laboratory study requisite for EPA registration. In the study, it eradicated both Clostridium Sporogenes and Bacillus Subtilis with 100% efficacy on both hard and porous surfaces. The company’s MedElite, Inc. subsidiary distributes clinically proven products to physicians who then prescribe the products for their patients. It recently became the owner of the Talsyn™-CI/bid Scar Cream, that has been clinically proven to facilitate and improve the appearance, redness and strength of scars (www.talsyn.com), as well as seven (7) other products in the Talsyn™ line. The Company is also owner of Cinnergen™, a clinically-studied, non-prescription liquid whole food nutritional supplement that promotes healthy glucose metabolism (www.cinnergen.com) and Cinnechol™, a new multi-faceted nutritional supplement specifically designed to naturally reduce total cholesterol levels without causing any side effects. The Company has entered into a joint venture agreement with CK41 Direct, Inc. to launch the PurEffect™ anti-acne skin care system. Please visit the Company’s website at: http://www.efoodsafety.com. Safe Harbor Forward-Looking Statements Statements contained in this release that are not strictly historical are "forward-looking” statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. The forward-looking statements are made based on information available as of the date hereof, and the Company assumes no obligation to update such forward-looking statements. Editors and investors are cautioned that such forward-looking statements involve risks and uncertainties that could cause the Company’s actual results to differ materially from those in these forward-looking statements. Such risks and uncertainties include but are not limited to demand for the Company’s products and services, our ability to continue to develop markets, general economic conditions, our ability to secure additional financing for the Company and other factors that may be more fully described in reports to shareholders and periodic filings with the Securities and Exchange Commission.